Biomedical Engineering Reference
In-Depth Information
FDA (1999)
Immunotoxicity Testing Guidance
, US Department Of Health And
Human Services, Food and Drug Administration, Center for Devices and Radio-
logical Health.
FI NK, J, FUHRMANN, R, SCHARNWEBER, T & FRANKE, R P (2008) Stimulation of monocytes
and macrophages: possible infl uence of surface roughness.
Clin Hemorheol Micro-
circulation
,
39
, 205-12.
FI SHBEIN, I, STACHELEK, S J, CONNOLLY, J M, WILENSKY, R L, ALFERIEV, I & LEVY, R J (2005)
Site specifi c gene delivery in the cardiovascular system.
J Control Release
,
109
,
37-48.
FYFE, B S, QUINTANA, C S, KANEKO, M & GRIEPP, R B (1994) Aortic sarcoma four years
after Dacron graft insertion.
Ann Thorac Surg
,
58
, 1752-4.
GEORGE, I, COLLEY, P, RUSSO, M J, MARTENS, T P, BURKE, E, OZ, M C, DENG, M C, MANCINI,
D M & NAKA, Y (2008) Association of device surface and biomaterials with immu-
nologic sensitization after mechanical support.
J Thorac Cardiovasc Surg
,
135
,
1372-9.
GERARD, C & GERARD, N P (1994) C5A anaphylatoxin and its seven transmembrane-
segment receptor.
Annu Rev Immunol
,
12
, 775-808.
GLAGOV, S, GIDDENS, D P, BASSIOUNY, H, WHITE, S S & ZARINS, C K (1991) Hemodynamic
effects and tissue reactions at graft to vein anastomosis for vascular access. IN
Sommer, B G & Henry, M L (Eds)
Vascular Access for Hemodialysis-II.
Chicago,
IL, W. L. Gore & Associates, Inc. and Precept Press, Inc.
GRABENWOGER, M, GRIMM, M, EYBL, E, KADLETZ, M, HAVEL, M, KOSTLER, P, PLENK, H, BOCK,
P & WOLNER, E (1992) New aspects of the degeneration of bioprosthetic
heart valves after long-term implantation.
J Thorac Cardiovasc Surg
,
104
,
14-21.
GRABENWOGER, M, FI TZAL, F, GROSS, C, HUTSCHALA, D, BOCK, P, BRUCKE, P & WOLNER, E
(2000) Different modes of degeneration in autologous and heterologous heart
valve prostheses.
J Heart Valve Dis
,
9
, 104-9; discussion 110-11.
GREGOR, R, CHRISTINA, T & ROSS, R B (1995) Bacterial biofi lms on devices used in
nephrology.
Nephrology
,
1
, 269-75.
GREISLER, H P (1991)
New Biologic and Synthetic Vascular Prostheses
.
Austin, TX,
R.G. Landes.
GUMMERT, J F, OPFERMANN, U, JACOBS, S, WALTHER, T, KEMPFERT, J, MOHR, F W & FALK, V
(2007) Anastomotic devices for coronary artery bypass grafting: technological
options and potential pitfalls.
Comput Biol Med
,
37
, 1384-93.
HAAHR-PEDERSEN, S, BJERRE, M, FL YVBJERG, A, MOGELVANG, R, DOMINQUEZ, H, HANSEN,
T K, GALATIUS, S, BECH, J, MADSEN, J K, SOGAARD, P & JENSEN, J S (2009) Level of
complement activity predicts cardiac dysfunction after acute myocardial infarc-
tion treated with primary percutaneous coronary intervention.
J Invasive Cardiol
,
21
, 13-19.
HABASH, M & REID, G (1999) Microbial biofi lms: their development and signifi cance
for medical device-related infections.
J Clin Pharmacol
,
39
, 887-98.
HANSCH, G M, SEITZ, M & BETZ, M (1987) Effect of the late complement compo-
nents C5b-9 on human monocytes: release of prostanoids, oxygen radicals and
of a factor inducing cell proliferation.
Int Arch Allergy Appl Immunol
,
82
,
317-20.
HARKEN, D E, SOROFF, H S, TAYLOR, W J, LEFEMINE, A A, GUPTA, S K & LUNZER, S (1960)
Partial and complete prostheses in aortic insuffi ciency.
J Thorac Cardiovasc Surg
,
40
, 744-62.
Search WWH ::
Custom Search